Atlas Trials

A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML

Clinical trial NCT01861002 · COMPLETED

Trial details

NCT number
NCT01861002
Sponsor
Therapeutic Advances in Childhood Leukemia Consortium
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Lymphoblastic Leukemia, Acute, ChildhoodMyelogenous Leukemia, Acute, Childhood
Start date
2013-05-22
Primary completion
2014-07-28
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.